Sculptor Capital LP Natera, Inc. Transaction History

Sculptor Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $9.1 Million - $14 Million	-246,533 Reduced 15.68%	1,326,229 $58.1 Million
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $1.07 Million - $1.69 Million	-38,051 Reduced 2.36%	1,572,762 $55.7 Million
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $10 Million - $30.1 Million	329,984 Added 25.76%	1,610,813 $65.5 Million
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $9.03 Million - $12.5 Million	104,634 Added 8.9%	1,280,829 $120 Million
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $1.4 Million - $1.76 Million	13,958 Added 1.2%	1,176,195 $131 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $100 Million - $139 Million	1,162,237 New	1,162,237 $132 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.